Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) EBT Margin: 2022-2023

Historic EBT Margin for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to 28,374.00%.

  • Lexeo Therapeutics' EBT Margin rose 137956.00% to 28,374.00% in Q4 2023 from the same period last year, while for Dec 2023 it was 32,386.83%, marking a year-over-year change of. This contributed to the annual value of 71,775.91% for FY2024, which is 3938860.00% up from last year.
  • According to the latest figures from Q4 2023, Lexeo Therapeutics' EBT Margin is 28,374.00%, which was down 26.62% from 38,669.23% recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year EBT Margin high stood at 38,669.23% for Q3 2023, and its period low was -3,211.86% during Q3 2022.
  • For the 2-year period, Lexeo Therapeutics' EBT Margin averaged around 25,583.36%, with its median value being 27,684.22% (2022).
  • Data for Lexeo Therapeutics' EBT Margin shows a peak YoY surged of 4,188,110bps (in 2023) over the last 5 years.
  • Over the past 2 years, Lexeo Therapeutics' EBT Margin (Quarterly) stood at 26,994.44% in 2022, then soared by 137,956bps to 28,374.00% in 2023.
  • Its last three reported values are 28,374.00% in Q4 2023, 38,669.23% for Q3 2023, and 25,360.38% during Q2 2023.